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The relation between hyperglycemia and diabetic neuropathy has already been
demonstrated in some studies. Among the theories proposed for its etiology the oxidative
stress stands out. The performance of nitric oxide as a link between the metabolic and
vascular neuropathogenic factors that triggers the diabetic neuropathy has already been
put forward. This study aimed to assess the quantification and measurements of the cell
body profile area (CBPA) of NADPH-diaphorase reactive (NADPH-dp) myenteric neurons
of the jejunum of diabetic rats (induced by streptozotocin) supplemented with Ascorbic
Acid (AA). These changes in the myenteric neurons seem to be related to the gastrointestinal
disturbances observed in diabetes mellitus (DM). Twenty male Wistar rats (Rattus
norvegicus) were distributed in 4 groups (n=5): controls (C), control supplemented (CS),
diabetic (D), and diabetic suplemented (DS). DM was induced by estreptozotocin (50mg/
kg body wt). One week after the induction and confirmation of the DM (glycemia exam),
animals of the groups CS and DS received 50mg of AA three times a week by gavage.
After 90 days of experiment, the animals were anesthetized with lethal thiopental dose
(40mg/kg) and the collected jejunum processed for the histochemistry NADPH-diaphorase
technique. Whole-mount preparations were obtained for quantitative and morphometric
analysis of the myenteric neurons. A quantity of jejunum neurons in the Group D (96±7.5)
was not different (P>0.05) from Group DS (116±8.08), C (92±9.7), and CS (81±5.4), but in
Group DS the quantity was higher (P<0.05) than in Group C and CS. The CBPA of neurons
from Group D (189.50±2.68μm2) and DS (195.92±3.75μm2) were lower (P<0.05) than from
Group C (225.13±4.37μm2) and CS (210.23±3.15μm2). The streptozotocin-induced DM
did not change the jejunum-ileum area, the jejunum myenteric plexus space organization
and the density of NADPH-dp neurons. The 50g AA-supplementation, three times a week,
during 90 days, did not decrease hyperglycemia; however, it had a neuroprotective effect
on the myenteric neurons, minimizing the increase on the CBPA of NADPH-dp neurons
and increasing the amount of NADPD-dp neurons.
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RESUMO.- [Avaliação dos neurônios NADPH-diaforase
reativos do jejuno de raots diabéticos suplementados
com ácido ascórbico.] A relação entre hiperglicemia e
neuropatia diabética foi demonstrada em várias pesqui-
sas. Entre as teorias propostas para sua etiologia desta-
ca-se o estresse oxidativo. O papel do óxido nítrico como
elo entre os fatores neuropatogênicos metabólico e
vascular que ativam a neuropatia diabética tem sido res-
saltado. Este estudo objetivou avaliar a quantificação e a
morfometria da área do perfil do corpo celular (CBPA) de
neurônios mioentéricos NADPH-diaforase reativos
(NADPH-dp) do jejuno de ratos diabéticos e suplementa-
dos com Ácido Ascórbico (AA), uma vez que alterações
nos neurônios mioentéricos parecem estar relacionadas
aos distúrbios gastrointestinais observados no diabetes
mellitus (DM). Vinte ratos machos da linhagem Wistar
(Rattus norvergicus) foram distribuídos em 4 grupos (n=5):
controle (C), controle suplementado (CS), diabético (D) e
diabético suplementado (DS). O DM foi induzido através
de injeção de estreptozootocina (50mg/kg de peso corpo-
ral). Uma semana depois da indução e confirmação do
DM (glicemia), animais dos grupos CS e DS receberam,
via gavagem, 50mg de AA três vezes por semana. Após
90 dias de período experimental, os animais foram
anestesiados com dose letal de thiopental intravenosa
(40mg/kg) e o jejuno foi retirado e processado para a téc-
nica histoquímica da NADPH-diaforase. Preparados de
membrana foram obtidos para análises quantitativa e
morfométrica dos neurônios mioentéricos. A quantidade
de neurônios do jejuno do Grupo D (96±7,5) não diferiu
(P>0,05) dos Grupos DS (116±8,08), C (92±9,7) e CS
(81±5,4), mas no Grupo DS o número de neurônios foi
superior (P<0,05) aos Grupos C e CS. A CBPA de
neurônios do Grupo D (189,50±2,68μm2) e DS
(195,92±3,75μm2) foi menor (P<0,05) do que a dos Gru-
pos C (225,13±4,37μm2) e CS (210,23±3,15μm2). O DM
induzido por estreptozootocina não alterou a área do
jejuno-íleo, a organização espacial do plexo mioentérico
e a densidade de neurônios de NADPH-dp do jejuno. A
suplementação de 50mg de AA, três vezes por semana,
durante 90 dias, não diminuiu a hiperglicemia, porém teve
efeito neuroprotetor nos neurônios mioentéricos,
minimizando o aumento na CBPA dos neurônios NADPH-
dp e aumentando a quantidade de neurônios reativos a
NADPD-diaforase.
TERMOS DE INDEXAÇÃO: Plexo mioentérico, intestino; vita-
mina C, antioxidantes, hiperglicemia.
INTRODUCTION
Diabetes mellitus (DM) affects animal and human beings
and is a multiple etiology disease. Its main manifestations
are due to disturbances in the metabolism of
carbohydrates, fats and proteins associated to an absolute
or relative deficiency in the insulin secretion by the
pancreas beta cells. This deficiency is responsible for the
chronic-degenerative complications along with vascular
and nervous compromising manifested as macro and
micro-angiopathies and neuropathies (Crawford & Cotran
1996). In animals, as dogs and cats, the DM can occur at
older ages mainly. Obesity and castration, besides age,
are also risk factors for the appearance of DM in cats
(Hoenig 2002).
The autonomic neuropathy is one among the several
neuropathies that arise in the DM in gastrointestinal level.
It leads to changes in the motor, sensorial and reflexive
activities (Clarke et al. 1979) in form of diarrhea and
constipation (Clements & Bell 1982), megacolon and
gastrointestinal transit slowness (Iber et al. 1993), stasis,
and gastric dilatation with reduction or increase of
peristaltic contractions, as well as more serious gastric
problems such as gastroparesis characterized by anorexy,
loss of weight, nauseas and vomits (Katz & Spiro 1966,
Clements & Bell 1982).
 Alterations in myenteric plexus are involved in the
gastrointestinal abnormalities seen in the autonomic
diabetic neuropathy. Studies have shown a decrease in
the neuronal activity and the development of chromatolysis
followed by degenerative changes (Monckton & Pehowich
1980). There is also a reduction in neuron number, within
short or long time, in the stomach (Fregonesi et al. 2001),
duodenum (Buttow et al. 1997), ileum (Hernandes et al.
2000), caecum (Zanoni et al. 1997), and proximal colon
(Romano et al. 1996, Furlan et al. 2002). Alterations in the
neurotransmitters levels have also been observed
(Balmann & Conlon 1985, Belai & Burnstock 1990),
suggesting neuropathy due to DM which does not affect
the myenteric neurons with the same intensity and
extension, with a possible reduction of some
neurotransmitters in some neurons, but not in others
(Vinson et al. 1989, Baynes 1991).
The relationship between hyperglycemia and diabetic
neuropathy has already been proven in some studies. The
oxidative stress stands out among the theories proposed
for its etiology (Giuliano et al. 1996, Afzaal et al. 2002).
The oxidative stress in this neuropathy and in other DM
complications is intensified by reduction in enzyme levels
that participate in the antioxidant defense system
(Parthiban et al. 1995, Obrosova et al. 2002), and also by
reduction in antioxidant levels such as ascorbic acid
(Young et al. 1992), glutathione and vitamin E (Lee &
Chung 1999).
Another potential mechanism for the rise of the oxidative
stress in the DM is the disproportionate increase in the
formation of free radicals due to glucose oxidation, non-
enzymic glycation of proteins and subsequent oxidative
degradation of the glycate proteins (Maritim et al. 2003),
and changes in the polyol pathway activity (Baynes 1991,
Ksiazek & Wisniewska 2001, Davison et al. 2002).
The hyperglycemia activates the aldose reductase and
sorbitol dehydrogenase, which are enzymes of the polyol
pathway that catalyzes the conversion of glucose into
sorbitol and fructose, respectively. Since the fructose and
phospho-fructose have a restraining effect on the functional
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activity, and since sorbitol and fructose do not spread out
easily along the plasmatic membrane, a gradual
accumulation of sorbitol and fructose inside the nervous
fibers takes place (Silva & Teixeira 1999). The conse-
quences of this accumulation are: 1) increase of the
intracellular osmolarity, with formation of edema, neuronal
injury and reduction of the nerve conduction (Hosking et
al. 1978); 2) reduction in the content of myoinisitol, resulting
in a decrease in the phosphoinositide metabolism and less
activity of diacylglycerol, protein kinase C and Na+/K+
ATPase (Crawford & Cotran 1996), leading to an axo-glial
disjunction and damaging the fiber, which may be the first
structural abnormality of the diabetic neuropathy; and 3)
reduction of the glutathione levels, both the glutathione
reductase and aldose reductase (Cameron et al. 1993).
The neurons that liberate nitric oxide (NO) play a crucial
inhibiting role in the motility control of the gastrointestinal
tube (Jarvinen et al. 1999). Some authors have already
proposed the NO action as the link between the metabolic
and vascular neuropathogenic factors that triggers the
diabetic neuropathy (Stevens et al. 1995). NO is produced
when the L-arginine is reduced to L-citruline by the action
of the enzyme nitric oxide synthase (NOS) (Olsson &
Holmgren 2001). The NOS enzyme is used to stain
neurons by reducing the nitroblue tetrazolium in the pre-
sence of beta-nicotinemide adenine dinucleotide
phosphate reduced (NADPH-reduced), which indicates
that the histochemical NADPH-diaphorase can be used
as an NO marker (Santer 1994).
Quantitative changes in the nitrergic neurons of the
myenteric plexus and a reduction in the NOS activity in
diabetic animals have been reported (Wrzos et al. 1997,
Spangéus et al. 2000, Watkins et al. 2000), reinforcing
the observation of a myenteric plexus compromising due
to the autonomic diabetic neuropathy. Multiple therapeutic
strategies have shown that the antioxidant treatments can
prevent or revert the peripheral nervous dysfunction in
streptozotocin-induced-diabetic rats (Cameron et al. 1993,
Cameron & Cotter 1999). The ascorbic acid supple-
mentation reduces the capillary fragility and the cellular
sorbitol concentration (Cunningham et al. 1998), sug-
gesting a neuroprotective effect of this substance.
The aim of this study was to quantify and assess the
morphometry of the NADPH-diaphorase stained neuron
population of the jejunum myenteric plexus of strepto-
zotocin-induced diabetic rats supplemented with AA, taking
into consideration the neuropathy relevance as one of the
chronic-degenerative complications due to DM.
MATERIALS AND METHODS
Twenty male rats (Rattus norvegicus) of Wistar lineage with 3
months of age, supplied by the Central Vivarium of the University
of São Paulo, were used.The animals were distributed in four
groups with five animals each (n=5) as follows: Group D
(diabetic); Group C (normoglycemic control); Group DS (diabetic
AA-supplemented), and Group CS (AA-supplemented
normoglycemic control).
The animals were housed in separate polypropylene cages,
at room temperature (24±2ºC) and controlled photoperiod (12
hours dark/light cycle) with access to food and water ad libitum.
During the 90-days experiment period, the animals were weighed
once a week.
This study was done within the guidelines of the COBEA
(Brazilian College for Animal Experimentation) and was
approved by the CEPEEA (Institutional Committee for Ethics in
Animal Experimentation) from Unipar.
Streptozotocin-induced diabetes mellitus and ascorbic acid
supplementation (AA)
After a previous 14 hours fasting, each animal of groups D
and DS received a single dose of streptozotocin (50mg/kg of
body weight) dissolved in sodium citrate buffer 10mm, pH 4.5,
through intravenous injection (penile vein). The animals from
Group C and CS received the same dose of 10mm sodium citrate
buffer. One week after the induction and confirmation of diabetes
onset (blood glucose exams), every animal from Group CS and
DS received 50mg of AA (through gavage), three times a week,
during 90 days.
Obtaining intestinal segments
At the end of the experimental period, after fasting for 12
hours, the animals were put down with a lethal dose of
anaesthetic (Thiopental Abbout® 40mg/kg) given by intravenous
injection. Blood was collected through cardiac punction in order
to measure the glucose levels (Bergmeyr & Bernet 1974). A
laparotomy was then carried out to retrieve the jejunum.
The jejunum-ileum area (mm2)
The length and diameter (mm) of the jejunum-ileum were
measured. The total area was estimated in the animals from
Group C, D, DS and CS. This procedure was used to show
possible changes in the intestinal area caused by the DM that
could hinder the neuronal quantification data.
NADPH-diaphorase histochemical technique (Scherer-
Singler et al. 1983)
The collected jejunums were washed and filled with
phosphate buffer (PB, pH 7.4), had their extremities tied with
suture thread, fixed in 4%  paraformaldehyde (Merck, Darmstadt,
Germany) prepared in phosphate buffer 0.1 M (PB, pH 7.4) for
30 min, immersed in 0.3% Triton X-100® (Sigma, St. Louis, USA)
dissolved in saline phosphate buffer (PBS, pH 7.4) for 10 min
and then washed 10 times (10 min each wash) in PBS The
jejunums later. The segments were washed twice in sodium
phosphate buffer solution (SPB) (10 minutes each), and fixed in
parafolmadeyde 4% for 30 minutes and followed by
permeabilization in SPB with 0.3% Triton X-100 dissolved in
sodium phosphate buffer  (pH 7,3) for 10 minutes and then
washed twice in SPB for 10 minutes each. Subsequently,
jejunums were incubated in a broth containing 50mg of Nitro
Blue Tetrazolium (Sigma®), 100mg of b-NADPH (Sigma®) and
0.3% Triton X-100 in buffered Tris-HCl drain plug (0.1M pH
7,6).
The histochemical reaction was controlled visually with the
aid of stereomicroscope and lasted for 100 minutes. After
incubation the samples were opened at the mesenteric
attachment and washed three times in PBS for five minutes,
were opened by cutting to sutures at their extremities and then
immersed in 4% paraformaldehyde solution.
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Obtaining the membrane whole-mounts
The jejunum was sectioned throughout the extension of the
mesenteric edge and microdissected in a glass plate, with the
aid of micro clamp and micro shears, under the stereomicroscope
with transillumination to remove the mucosal layer and the
submucosal screen, preserving the muscular and serosal layers.
Each membrane whole-mount was dehydrated in a ascending
series of alcohols (90-100%) and clarified by three consecutive
immersions in xylol, then placed between glass blade with
Permount resin. The membrane whole-mount preparations were
used for the quantification and morphometric analyses of the
cellular body profile area of myenteric neurons.
Quantification of NADPH-diaphorase positive neurons
The jejunum membrane whole-mount was visualized by light
microscope in order to perform the neuronal quantification area
(mm2). The image seen in the microscope was captured by a
high resolution digital camera and transferred to a computer.
The neurons were quantified by means of a system test
adapted to each membrane whole-mount consisting of 60 fields.
Based on the width and length of the membrane whole-mount
preparations, the 60 fields were distributed as ten columns with
6 lines each, sampling all regions (mesenteric, intermediate and
anti-mesenteric). As the jejunum varies in its circumference, a
rectangular sampling test system with fixed dimensions could
not be adjusted for this material. Therefore, we needed to make
an adjustment for each column inside the membrane whole-
mount preparation. However, the column points were adjusted
so that they kept the same distance between themselves.
Measurement of the cell body profile area of NADPH-
diaphorase positive neurons
The measurement of the cell body profile area (CBPA) of
NADPH-diaphorase positive (NADPH-dp) myenteric neurons
was carried through image-analyses software (Image-Pro-Plus
3.0.1). The images of the neurons captured for digital chamber
for the quantification of the neuronal density had been used.
The CBPA (in ìm2) of all the neurons quantified previously in the
membrane whole-mount preparations of each animal for group
had been measured. The neurons had been grouped by class
intervals of 100μm2.
Statistical analysis
 The data related to the neuronal quantification were
analyzed by the Kruskal-Wallis test to compare the groups. As
for the data concerning the animals’ weight, blood glucose levels,
jejunum-ileum area and the neurons CBPA of different groups
were compared by the test of Tukey. The adopted significance
level for all groups was P<0.05. All the results were expressed
as mean ± standard error.
RESULTS
The animals from all groups gained weight (Table 1)
throughout the 90-days experiment period. However,
animals from Group D and DS gained less weigh (although
not in a significant way P>0.05) when compared to animals
from Group C and CS (Table 1).
The blood glucose dosage performed at the beginning
and at the end of the experiment confirmed the diabetes
presence in the animals from groups D and DS, which
showed higher blood glucose concentration (P>0.05) than
those in groups C and CS. There was no difference (P>0.05)
between the glucose values of Group D and DA (Table 2).
The jejunum-ileum surface area was similar among
Group C, CS, D and DS. The DM and the AA supple-
mentation did alter this parameter (Table 2).
The myenteric plexus presented NADPH-dp inside the
ganglions crossconnected by fiber bundles in the jejunum
whole-mounts of animals from all groups (Fig.1). The
quantification of NADPH-dp neurons was carried out through
a test system in 60 microscopic fields per membrane whole-
mount. The corresponding area to the 60 fields was 13.26
mm2. The neuronal density of Group D (95±7.5) was not
different (P>0.05) from the other groups and was higher
(P<0.05) in the jejunum of Group DS (116±8.08) than in
Group C (92±9.7) and CS (81±5.4) (Table 3).
The CBPA in the neurons of Group C ranged from 58.68
to 471.72μm2; from 82.71 to 423.78μm2 in Group CS; from
Table 3. Means and standard error of the average density
of NADPH-dp myenteric neurons in  13.26 mm2 the
jejunum and the cell body profile area (CBPA) in animals
from  Group C (normoglycemic), CS (normoglycemics
AA-supplemented), D (diabetic), and DS (diabetic AA-
supplemented)
Group Neuronal density CBPA (mm2)
C (n =5) 92ªb±9.7 225.13a±4.37
CS (n =5) 81ª±5.4 210.23b±3.15
D (n =5) 95ab±7.5 189.50c±2.68
DS (n =5) 116b±8.08 195.92c±3.75
Means followed by different letters in the same column are different
(P<0.05) by the test of Kruskal-Wallis for the neuronal density and by
the test of Tukey for the cell body profile area.
Table 2. Initial and final glycemia and jejunum-ileum
surface area (mm2) means of rats from groups C
(normoglycemic), CS (normoglycemic AA-supplemented),
D (diabetic) and DS (diabetic AA-supplemented)
Group Initial glycemia Final glycemia Jejunum-ileum area
(mg.dl-1) (mg.dl-1)
C (n =5) 101.3ª±5.26       101.3ª±3.54 1128±35.91a
CS (n =5) 97.25a±4.73            95ª±2.85 1232±31.27a
D (n =5) 387b±16.97       446.5b±5.33 1218±30.89a
DS (n =5) 395.5b±4.62       436.5b±1.37 1198±41.04a
Means followed by different letters in the same line and column are
different (P<0.05) by the test of Tukey.
Table 1. Body weight at 90-days and at 180-days of age of
rats from groups C (normoglycemic), CS (normoglycemic
AA-supplemented), D (diabetic) e DS (diabetic AA-
supplemented)
Group Initial weight (g) Final weight (g)
C (n =5) 295ª±15.81 430.3b±27.4
CS (n =5) 301,5ª±2.02  430.4b±20.39
D (n =5) 283,3ª±11.24 395.5b±31.2
DS (n =5) 314ª±12.25 367.5b± 59.25
Means followed by different letters in the same line and column are
different (P<0.05) by the test of Tukey
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77.43 to 360.03μm2 in Group D and from 58.68 to
440.76μm2 in Group DS. The CBPA of neurons from Group
D (189.50±2.68) and DS (195.92±3.75) were lower
(P<0.05) than Group C (225.13±4.37μm2) and CS
(210.23±3.15μm2) (Table 3).
The relative frequency of neurons of each group
according to class intervals regarding the dimensions of
the CBPA can be seen on Table 4. In all groups there was
a prevalence of neurons with a cell body profile area in
the class interval between 100 and 300μm2 (Fig 2).
DISCUSSION
The streptozotocin injection with a dose of 50mg/kg of body
weight was efficient in the induction of diabetes in the
animals from Group D and DS. At the end of the experiment
that lasted 90 days, the glycemia in Group D
(446.5±5.33mg-dl-1) and in Group DS (436.5±1.37mg-dl1)
was higher (P<0.05) than those in Group C (101.3±3.54mg-
dl-1), and CS (95±2.85mg-dl-1). This result was expected
since the streptozotocin given in doses higher than 25mg/
kg is diabetogenic (Ar’rajab & Ahrén 1993) and has been
Fig.2. Frequency histogram of HADPH-dp myenteric neurons
from Group C (normoglycemic), CS (normoglycemic AA-
supplemented), D (diabetic), and DS (diabetic AA-
supplemented) according a class interval of the cell body
profile area in μm2.
Table 4. Relative frequency (%) of NADPH-dp myenteric
neurons from the jejunum of rats from Group C
(normoglycemic), CS (normoglycemic AA-supplemented),
D (diabetic), and DS (diabetic AA-supplemented)
according to the cell body profile area at class intervals
of 100 μm2
Area μm2 Relative frequency of neurons (%)
Group C Group D Group CS Group DS
(n=5) (n=5) (n=5) (n=5)
<100 4 3 2 9
100    ¾ 200 43 59 44 46
200   ¾ 300 32 33 45 34
300    ¾ 400 16 5 8 10
>400 5 - 1 1
Total 100 100 100 100
⊥
⊥
⊥
Fig.1. Ganglions from the jejunum myenteric plexus showing NADPH-diaphorase reactive neurons. 400x. Bar: 50μm.
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used on diabetes research (Szkudelski 2001). The AA-
supplementation of diabetic and normoglycemic animals
did not interfere in the glucose blood concentration, since
the glycemia concentrations in the animals from group DS
were similar to those from Group D, showing the little effect
of the AA on the glycemia concentration as described by
Young et al. (1992).
At the beginning of the experiment, there was no
difference (P>0.05) in the body weight of animals from
Group C, CS, D, and DS. These results were kept until
the end of the experiment. The weight gain in Group D
(112.2g) and DS (53.5g) was lower than  those in Group C
(135.3g) and CS (128.9g), although they were not
significantly (P>0,05) differing from the results of other
experiments. In rats, Thulesen et al. (1997) reported that
the diabetic animals lost 16% of weight when compared
to normoglycemic animals. Lindsay et al. (1998) observed
a loss of 25.6% in the weight of diabetic rats and Furlan et
al. (2002) observed a loss of 19.6% of body weight. The
difference observed in the results and those mentioned in
literature may be due to the duration of the experiment
that, in this study, was 90 days while in the others was
120 days or one week. It was also verified that the AA
supplementation did not interfere in the weight gain among
the groups.
The oxidative stress intensification in the DM has
already been reported (Ksiazek & Wisniwska 2001,
Davison et al. 2002). According to Feldman (2003), the
accumulation of superoxides, activity increase of the polyol
pathway, accumulation of AGEs products (advanced
glycation end), change in the activity of the protein kinase-
C and in the hexosamine pathway flow trigger a gradual
cellular dysfunction in diabetes. Each pathway is altered
in a direct or indirect consequence of the overproduction
of superoxides by the electron transport chain in the
mitochondria, mediated by the hyperglycemia. Thus, it is
expected that the inhibition of the superoxide production
or the euglycemia may restore the metabolic and vascular
balance and block the onset and the progression of
complications in the organism.
The use of antioxidants and inhibitor of aldose-
reductase (essential for the polyol pathway) has been
investigated with intention to minimize or prevent the
deleterious effect of DM. The AA is an antioxidant (Levine
1986) and an inhibitor of the aldose-reductase (Will & Byers
1996), but its concentration in diabetic rats and in diabetic
human beings is low (McLennam et al. 1988).
When the blood glucose increases there is a reduction
in the amount of AA in the blood, although the opposite is
not true (Young et al. 1992). In this experiment, the animals
received 50mg of AA, through gavage, three times a week,
an amount one time higher than the amount of AA
synthesized daily by rats (Young et al. 1992). However,
this higher dosage did not hinder the glycemia increase in
animals from Group DS.
The jejunum-ileum area of all animals was measured
to assess possible changes in the muscular tonus and, as
observed in caecum (Zanoni et al. 1997) and in the
stomach (Clebis et al. 2004) of diabetic and normoglycemic
rats, with no significant differences (P>0.05) between
Group C (1128±35.91mm2), D (1218±30.89mm2), CS
(1232±31.27mm2), and DS (1198±41.04mm2). These
results indicated that the jejunum-ileum area was neither
affected by the DM nor by the AA-supplementation.
According to Irwin (1931), the myenteric neurons in the
muscular layer of the gastrointestinal tube are gathered in
ganglions crossconnected by nerve fibers forming, thus,
a ganglionated mesh or net. A similar display of the
myenteric plexus was observed in the jejunum membrane
whole-mount in all groups, indicating that the DM and the
AA supplementation did not modify the space display of
jejunum myenteric plexus.
In order to assess the effect of the DM and the AA
supplementation on the NADPH-dp myenteric neurons, it
was quantified the neurons in a total area of 13.26mm2 of
the jejunum per animal, and measured the cell body profile
area.
A quantity of jejunum neurons in the Group D (96±7.5)
was not different (P>0.05) from Group DS (116±8.08), C
(92±9.7), and CS (81±5.4), but in Group DS the quantity
was higher  (P<0.05) than Group C and CS, proving that
the diabetes did not interfere in the quantity of NADPH-dp
neurons of diabetic rats  but that the AA supplementation
allowed the evidenciation of a higher number of neurons
reactive to the enzyme NADPH-diaphorase in a
hyperglycemia condition. A decrease in the number of
neurons reactive to the NADH-diaphorase and of neurons
stained by the immunomarker myosin V or evidenced by
the methylene blue has been observed in the duodenum
(Büttow & Miranda-Neto 1997), in the large intestine as a
whole (Hernandes et al. 2000), in the caecum (Zanoni et
al. 1997) and in the proximal colon (Furlan et al. 2002,
Romano et al. 1996) in the diabetes mellitus. However,
there were reports of an increase in the quantity of NADPH-
dp myenteric neurons in the stomach pyloric area
(Fregonesi et al. 2005) and no significant change in the
quantity of NADPH-dp neurons in the ileum was observed
by Zanonni et al. (2003). Similarly, Wrzos et al. (1997)
verified that the nitric oxid synthase expression in the
duodenum, ileum and colon of diabetic rats did not differ
from those observed in the controls.
The DM interfered on the CBPA decreasing the neuron
CBPA size since there was a difference (P<0.05) between
Group D (189.50±2.68μm2) and DS (195.92±3.75μm2)
when compared to Groups C (225.13±4.37μm2) and CS
(210.23±3.15μm2), and although not significant (P>0.05)
this decrease on the neurons CBPA size was less sharp
in Group DS. Fregonesi et al. (2005) obtained different
results in the pyloric region of diabetic rats, in which the
NADPH-dp neurons had a higher CBPA than the
normoglycemic group, the same occurring in the in the
ileum (Zanoni et al. 2003) and in the other stomach areas
(Fregonesi et al. 2002, 2005). However, the neurons size
in Group DS (195.92±3.75μm2) and CS (186.87±
Pesq. Vet. Bras. 28(2):95-102, fevereiro 2008
Assessment of NADPH-diaphorase stained myenteric neurons of the jejunum of diabetic rats supplemented with ascorbic acid 101
16.88μm2) was significantly (P<0.05) smaller than those
from Group D and C, respectively. Thus, it seems that
after a certain period of the supplementation, the AA
antioxidant action, or even the inhibiting action of the
enzyme aldose-reductase, might have contributed to
diminish the oxidative stress in the diabetic rats (Group
DS) and the natural oxidative stress in the normoglycemic
rats (Group CS). It might have also hindered the sorbitol
accumulation that leads to neuronal edema, allowed the
nitrergic neurons to express NOS in a smaller concen-
tration and, as a result of the smaller NOS production,
decreasing its cellular activity, making the neuron a smaller
cell or, even, avoiding the edema and the neuronal death.
It is worth to notice that 62% of the neurons from Group D
and 55% of the neurons from Group DS had a CBPA lower
than 200mm2. In Group C and CS, 53% and 54% of the
neurons, respectively, presented a cell profile area higher
than 200mm2. A similar effect was observed by Zanoni et
al. (2003) in the nitrergic neurons of myenteric plexus and
in the immunoreactive neurons for the reactive vasointes-
tinal peptide of submucous plexus of the ileum of rats
(Zanoni et al. 2002).
As the NO is an inhibitory neurotransmitter, its increase
could intensify the muscular relaxation of the digestive tube
causing a reduction in the emptying of segments such as
the stomach (Fregonesi et al. 2005) and, when in reduced
concentration it could, obviously, promote the opposite, that
is, to diminish the relaxation of the gastrointestinal smooth
muscles, speeding up the transit and favoring the diarrhea.
The DM seems to inhibit the NO production in the
jejunum myenteric neurons. This effect is compensated in
the AA supplementation that promoted the increase in the
amount of neurons that express NO in the diabetes.
Summing up, the treatment with AA with a 50mg dose,
three times a week, seems to interfere with the density of
nitrergic neurons increasing the quantity of these neurons
in diabetic animals (Group DS) and hindering the increase
of the cell body profile that could speed up or intensify the
neuronal loss in animals with DM, since the supplemented
animals (Group CS and DS) presented a cellular profile
lower than the normoglycemic (Group C).
CONCLUSIONS
The results of this study led to reach the following
conclusions:
The streptozotocin-induced DM in rats with a single
dose of 50mg/kg of body weight  and kept for 90 days
from the 90-days of age did not change the jejunum-ileum
area, the muscular layer thickness, the space organization
of the myenteric plexus in the jejunum and the NADPH-dp
neurons density;
The 50g AA-supplementation, three times a week, via
gavage, during 90 days, did not decrease the hyper-
glycaemia, but had a neuroprotector effect on the myenteric
neurons, minimizing the increase on cell body profile area
of NADPH-dp neurons and increasing the quantity of
NADPH-dp neurons.
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